Morgan Stanley Direct Lending (MSDL) Q4 2025 earnings review
The Defensive Facade Cracks: Dividend Cut as Yields and Credit Deteriorate
Morgan Stanley Direct Lending's 'stable, defensive' narrative unraveled in Q4. Net Investment Income (NII) fell to $0.49 per share, finally breaking below the long-standing $0.50 dividend payout. Unsurprisingly, management cut the Q1 2026 dividend to $0.45. The squeeze is coming from both ends: Fed rate cuts dragged portfolio yields down to 9.5%, while non-accruals steadily accelerated to 1.6% of amortized cost. With on-balance-sheet leverage now maxed out at 1.20x, the company is turning to a newly launched Joint Venture to find off-balance-sheet growth, but the immediate story is one of declining asset value and retreating income.
🐂 Bull Case
The launch of Capstone Lending LLC creates a new structural lever for ROE. By partnering with an institution to deploy up to $250M, MSDL can generate fee income and off-balance-sheet returns without breaching its 1.20x leverage cap.
Management took advantage of the stock's discount, aggressively repurchasing 534,908 shares at $17.03 in Q4—more than triple the Q3 volume. A new $100M authorization secures a floor for the stock while accreting NAV.
🐻 Bear Case
A BDC's primary appeal is income reliability. The 10% cut to the regular dividend (to $0.45) confirms that previous warnings about interest rate sensitivity were accurate, and NII cannot support the historical payout.
Non-accruals have climbed for four consecutive quarters, reaching 1.6% of amortized cost. Combined with $13.7M in net realized and unrealized losses in Q4, underlying portfolio health is demonstrably weakening.
⚖️ Verdict: 🔴
Bearish. MSDL was pitched as a highly insulated, premium-tier credit vehicle. However, the combination of a dividend cut, steadily eroding NAV, and rising non-accruals shows it is just as vulnerable to rate cycles and credit fatigue as lower-tier peers.
Key Themes
Rate Headwinds Force a Dividend Cut
The long-feared interest rate squeeze has materialized. Weighted average yield on debt investments decelerated from 10.5% a year ago to 9.5% in 25Q4. This dragged total investment income down to $96.6M (from $99.7M in Q3). With NII at $0.49, management had no choice but to rebase the dividend to $0.45 for Q1 2026. This is a reversing trend from the previously stable $0.50 payout.
Non-Accruals: A Slow, Steady Bleed
Management has historically categorized credit issues as 'idiosyncratic', but the data shows an accelerating trend. Non-accruals rose to 1.6% of total investments at amortized cost. While the number of companies on non-accrual stayed flat at four, the percentage increase implies further financial deterioration or restructuring within those specific positions.
On-Balance-Sheet Growth Has Paused
With leverage hitting 1.20x, the company has reached the ceiling of its stated 1.15x-1.20x target range. Consequently, portfolio growth ground to a halt: Q4 saw $163.8M in fundings perfectly offset by $162.6M in repayments, resulting in net funded deployment of just $1.2M. The company cannot grow its way out of the NII hole using its own balance sheet.
Capstone Lending JV: The New Growth Lever
Because on-balance-sheet leverage is capped, management launched Capstone Lending LLC subsequent to quarter-end. MSDL will contribute up to $200M alongside a $50M JV partner. This allows MSDL to utilize off-balance-sheet leverage to boost ROE, a critical driver now that base rates are working against the core portfolio.
Other KPIs
The portfolio recorded $8.1M in net realized losses and $5.6M in net unrealized depreciation. This marks a continuation of NAV erosion, driving the per-share value down another $0.15 sequentially to $20.26.
Accelerating dramatically from 151,417 shares in Q3. The company bought back shares at an average price of $17.03—an approximate 16% discount to NAV. This was highly accretive, but indicates the market had already priced in the incoming fundamental weakness.
Stable. The combined weighted average interest rate on debt was 5.61%. While the company effectively reduced its funding costs in previous quarters via CLOs and refinancing, the liability cost reductions were outpaced by the drop in asset yields.
Guidance
Reversing. A 10% deceleration/cut from the $0.50 rate that was held throughout 2024 and 2025. This resets the baseline yield for the stock and reflects the reality of lower SOFR base rates flowing entirely through the floating-rate portfolio.
Stable. The Board authorized a new 24-month program to replace the 2025 program. Given the stock's current discount to NAV, expect this to be a highly utilized tool to provide a floor for the share price.
Key Questions
Non-Accrual Concentration
The non-accrual rate climbed to 1.6% of amortized cost, yet the total number of companies remained at four. Does this increase reflect additional capital injected into distressed names, or specific restructurings that resulted in higher cost-basis non-accruals?
Dividend Sustainability
With the dividend rebased to $0.45, what forward curve for base rates is this payout level calibrated against? Is $0.45 sustainable if the Fed cuts another 50-75 basis points in 2026?
Joint Venture Economics
Regarding the newly launched Capstone Lending JV, what is the target leverage profile inside the vehicle, and how quickly do you expect to call the remaining 53% of capital to drive ROE accretion?